Deutsche Bank’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,300
Closed -$42K 4265
2021
Q3
$42K Buy
+3,300
New +$45.7K ﹤0.01% 4143
2019
Q4
Sell
-2,372
Closed -$24K 4996
2019
Q3
$24K Sell
2,372
-117,145
-98% -$1.58M ﹤0.01% 4253
2019
Q2
$1.86M Buy
119,517
+52,120
+77% +$931K ﹤0.01% 2437
2019
Q1
$1.23M Buy
67,397
+19,697
+41% +$349K ﹤0.01% 2855
2018
Q4
$794K Buy
47,700
+28,274
+146% +$655K ﹤0.01% 3033
2018
Q3
$548K Buy
19,426
+16,400
+542% +$471K ﹤0.01% 3729
2018
Q2
$86K Sell
3,026
-12,587
-81% -$375K ﹤0.01% 4595
2018
Q1
$491K Buy
15,613
+14,617
+1,468% +$462K ﹤0.01% 3710
2017
Q4
$29K Sell
996
-69,204
-99% -$1.88M ﹤0.01% 4581
2017
Q3
$2M Buy
70,200
+41,200
+142% +$1.07M ﹤0.01% 2544
2017
Q2
$747K Buy
29,000
+23,600
+437% +$563K ﹤0.01% 3211
2017
Q1
$129K Buy
5,400
+1,800
+50% +$37.8K ﹤0.01% 3799
2016
Q4
$61K Sell
3,600
-67,371
-95% -$1.24M ﹤0.01% 4290
2016
Q3
$1.71M Buy
70,971
+44,878
+172% +$1.17M ﹤0.01% 2462
2016
Q2
$693K Buy
26,093
+12,930
+98% +$379K ﹤0.01% 3099
2016
Q1
$361K Sell
13,163
-28,968
-69% -$698K ﹤0.01% 3379
2015
Q4
$1.31M Buy
42,131
+28,968
+220% +$879K ﹤0.01% 2714
2015
Q3
$346K Hold
13,163
﹤0.01% 3558
2015
Q2
$474K Buy
13,163
+12,663
+2,533% +$444K ﹤0.01% 3426
2015
Q1
$17K Buy
+500
New +$18.1K ﹤0.01% 4697

Other funds holding CLLS

Deutsche Bank's CLLS Position: Q4 2021 in Review

Deutsche Bank sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 3,300 shares — an estimated $42K sold.

Deutsche Bank first reported a position in CLLS in Q1 2015 and held it in 20 quarters. The position peaked at $2M in Q3 2017. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • Deutsche Bank reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • Deutsche Bank sold 3,300 Cellectis shares in Q4 2021, an estimated $42K.
  • Deutsche Bank first reported a position in Cellectis in Q1 2015 and held it in 20 quarters.
  • Deutsche Bank's Cellectis position peaked at $2M in Q3 2017.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.